Difference between revisions of "Template:Cell surface receptor deficiencies"
Jump to navigation
Jump to search
imported>Arcadian (Waardenburg) |
imported>DePiep (rm Mednav index templates. See talk (via AWB script)) |
||
| (14 intermediate revisions by 11 users not shown) | |||
| Line 1: | Line 1: | ||
{{Navbox | {{Navbox | ||
| − | |name | + | | name = Cell surface receptor deficiencies |
| − | |title | + | | title = [[Cell surface receptor]] deficiencies |
| − | | | + | | state = {{{state|autocollapse}}} |
| − | | | + | | bodyclass = hlist |
| − | | | ||
| + | | group2 = [[G protein-coupled receptor]]<br>(including [[Hormone receptor|hormone]]) | ||
| + | | list2 = | ||
| + | {{Navbox|subgroup | ||
| + | | group1 = Class A | ||
| + | | list1 = | ||
| + | * ''[[Thyrotropin receptor|TSHR]]'' ([[Congenital hypothyroidism|Congenital hypothyroidism 1]]) | ||
| + | * ''[[Luteinizing hormone/choriogonadotropin receptor|LHCGR]]'' ([[Luteinizing hormone insensitivity]], [[Leydig cell hypoplasia]], [[Male-limited precocious puberty]]) | ||
| + | * ''[[FSH-receptor|FSHR]]'' ([[Follicle-stimulating hormone insensitivity]], [[XX gonadal dysgenesis]]) | ||
| + | * ''[[Gonadotropin-releasing hormone receptor|GnRHR]]'' ([[Gonadotropin-releasing hormone insensitivity]]) | ||
| + | * ''[[Endothelin receptor|EDNRB]]'' ([[ABCD syndrome]], [[Waardenburg syndrome|Waardenburg syndrome 4a]], [[Hirschsprung's disease|Hirschsprung's disease 2]]) | ||
| + | * ''[[AVPR2]]'' ([[Nephrogenic diabetes insipidus|Nephrogenic diabetes insipidus 1]]) | ||
| + | * ''[[Prostaglandin E2 receptor|PTGER2]]'' ([[Aspirin-induced asthma]]) | ||
| − | |group2 = [[ | + | | group2 = Class B |
| − | + | | list2 = | |
| + | * ''[[PTH1R]]'' ([[Jansen's metaphyseal chondrodysplasia]]) | ||
| − | | | + | | group3 = Class C |
| − | | | + | | list3 = |
| + | * ''[[Calcium-sensing receptor|CASR]]'' ([[Familial hypocalciuric hypercalcemia]]) | ||
| − | | | + | | group4 = Class F |
| − | | | + | | list4 = |
| + | * ''[[FZD4]]'' ([[Familial exudative vitreoretinopathy|Familial exudative vitreoretinopathy 1]]) | ||
| + | }} | ||
| + | | group4 = [[Enzyme-linked receptor]]<br>(including<br>[[Growth factor receptor|growth factor]]) | ||
| + | | list4 = | ||
| + | {{Navbox|subgroup | ||
| + | | group1 = [[Receptor tyrosine kinase|RTK]] | ||
| + | | list1 = | ||
| + | * ''[[ROR2]]'' ([[Robinow syndrome]]) | ||
| + | * ''[[Fibroblast growth factor receptor 1|FGFR1]]'' ([[Pfeiffer syndrome]], [[Kallmann syndrome|KAL2 Kallmann syndrome]]) | ||
| + | * ''[[Fibroblast growth factor receptor 2|FGFR2]]'' ([[Apert syndrome]], [[Antley–Bixler syndrome]], [[Pfeiffer syndrome]], [[Crouzon syndrome]], [[Jackson–Weiss syndrome]]) | ||
| + | * ''[[Fibroblast growth factor receptor 3|FGFR3]]'' ([[Achondroplasia]], [[Hypochondroplasia]], [[Thanatophoric dysplasia]], [[Muenke syndrome]]) | ||
| + | * ''[[Insulin receptor|INSR]]'' ([[Donohue syndrome]] | ||
| + | * [[Rabson–Mendenhall syndrome]]) | ||
| + | * ''[[TrkA receptor|NTRK1]]'' ([[Congenital insensitivity to pain with anhidrosis]]) | ||
| + | * ''[[CD117|KIT]]'' ([[Piebaldism|KIT Piebaldism]], [[Gastrointestinal stromal tumor]]) | ||
| − | | | + | | group2 = [[Serine/threonine-specific protein kinase|STPK]] |
| − | | | + | | list2 = |
| + | * ''[[Anti-Müllerian hormone receptor|AMHR2]]'' ([[Persistent Müllerian duct syndrome|Persistent Müllerian duct syndrome II]]) | ||
| − | | | + | * [[TGF beta receptors]]: [[Endoglin]]/[[ACVRL1|Alk-1]]/[[Mothers against decapentaplegic homolog 4|SMAD4]] ([[Hereditary hemorrhagic telangiectasia]]) |
| − | | | + | * [[TGF beta receptor 1|TGFBR1]]/[[TGF beta receptor 2|TGFBR2]] ([[Loeys–Dietz syndrome]]) |
| − | + | | group3 = [[Guanylate cyclase|GC]] | |
| − | + | | list3 = | |
| − | + | * ''[[GUCY2D]]'' ([[Leber's congenital amaurosis|Leber's congenital amaurosis 1]]) | |
| − | + | }} | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | | group3 = [[Guanylate cyclase|GC]] | ||
| − | | list3 = ''[[GUCY2D]]'' ([[Leber's congenital amaurosis|Leber's congenital amaurosis 1]]) | ||
| − | |||
| − | }} | ||
| group5 = [[JAK-STAT signaling pathway|JAK-STAT]] | | group5 = [[JAK-STAT signaling pathway|JAK-STAT]] | ||
| − | | list5 = [[Type I cytokine receptor]]: ''[[Growth hormone receptor|GH]]'' ([[Laron syndrome]]) | + | | list5 = |
| − | + | * [[Type I cytokine receptor]]: ''[[Growth hormone receptor|GH]]'' ([[Laron syndrome]]) | |
| + | * ''[[Granulocyte macrophage colony-stimulating factor receptor|CSF2RA]]'' ([[Surfactant metabolism dysfunction|Surfactant metabolism dysfunction 4]]) | ||
| − | [[Myeloproliferative leukemia virus oncogene|MPL]] ([[Congenital amegakaryocytic thrombocytopenia]]) | + | * [[Myeloproliferative leukemia virus oncogene|MPL]] ([[Congenital amegakaryocytic thrombocytopenia]]) |
| group6 = [[Tumor necrosis factor receptor|TNF receptor]] | | group6 = [[Tumor necrosis factor receptor|TNF receptor]] | ||
| − | | list6 = ''[[TNFRSF1A]]'' ([[TNF receptor associated periodic syndrome]]) | + | | list6 = |
| − | + | * ''[[TNFRSF1A]]'' ([[TNF receptor associated periodic syndrome]]) | |
| + | * ''[[TNFRSF13B]]'' ([[Selective immunoglobulin A deficiency|Selective immunoglobulin A deficiency 2]]) | ||
| + | * ''[[CD40 (protein)|TNFRSF5]]'' ([[Hyper-IgM syndrome type 3]]) | ||
| + | * ''[[TNFRSF13C]]'' ([[Common variable immunodeficiency|CVID4]]) | ||
| + | * ''[[TNFRSF13B]]'' ([[Common variable immunodeficiency|CVID2]]) | ||
| + | * ''[[Fas receptor|TNFRSF6]]'' ([[Autoimmune lymphoproliferative syndrome|Autoimmune lymphoproliferative syndrome 1A]]) | ||
| group7 = Lipid receptor | | group7 = Lipid receptor | ||
| − | | list7 = [[Lipoprotein receptor-related protein|LRP]]: ''[[LRP2]]'' ([[ | + | | list7 = |
| + | * [[Lipoprotein receptor-related protein|LRP]]: ''[[LRP2]]'' ([[Donnai–Barrow syndrome]]) | ||
| + | * ''[[Low density lipoprotein receptor-related protein 4|LRP4]]'' ([[Cenani–Lenz syndactylism]]) | ||
| + | * ''[[LRP5]]'' ([[Worth syndrome]], [[Familial exudative vitreoretinopathy|Familial exudative vitreoretinopathy 4]], [[Osteopetrosis|Osteopetrosis 1]]) | ||
| − | ''[[LDL receptor|LDLR]]'' ([[Familial hypercholesterolemia|LDLR Familial hypercholesterolemia]]) | + | * ''[[LDL receptor|LDLR]]'' ([[Familial hypercholesterolemia|LDLR Familial hypercholesterolemia]]) |
| group10 = Other/ungrouped | | group10 = Other/ungrouped | ||
| − | | list10 = [[Immunoglobulin superfamily]]: [[Hypogammaglobulinemia|AGM3, 6]] | + | | list10 = |
| + | * [[Immunoglobulin superfamily]]: [[Hypogammaglobulinemia|AGM3, 6]] | ||
| − | [[Integrin]]: [[Leukocyte adhesion deficiency-1| | + | * [[Integrin]]: [[Leukocyte adhesion deficiency-1|LAD1]] |
| + | * [[Glanzmann's thrombasthenia]] | ||
| + | * [[Junctional epidermolysis bullosa with pyloric atresia]] | ||
| − | ''[[EDAR]]'' ([[Hypohidrotic ectodermal dysplasia|EDAR | + | ''[[EDAR]]'' ([[Hypohidrotic ectodermal dysplasia|EDAR hypohidrotic ectodermal dysplasia]]) |
| + | * ''[[PTCH1]]'' ([[Nevoid basal-cell carcinoma syndrome]]) | ||
| + | * ''[[BMPR1A]]'' ([[Juvenile polyposis syndrome|BMPR1A juvenile polyposis syndrome]]) | ||
| + | * ''[[IL2RG]]'' ([[X-linked severe combined immunodeficiency]]) | ||
| − | + | ;See also | |
| − | + | : [[Template:Cell surface receptors|cell surface receptors]] | |
| + | }}<noinclude> | ||
| + | {{collapsible option}} | ||
| + | [[Category:Cell surface receptor deficiencies]] | ||
| + | [[Category:Genetic disease and disorder templates by mechanism]] | ||
| + | </noinclude> | ||
Latest revision as of 16:58, 13 February 2016
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Cell surface receptor deficiencies|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Cell surface receptor deficiencies|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Cell surface receptor deficiencies|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.